{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T15:37:35Z","timestamp":1757777855494},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"no funding"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12884-017-1300-1","type":"journal-article","created":{"date-parts":[[2017,4,26]],"date-time":"2017-04-26T02:01:24Z","timestamp":1493172084000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Management of suspected primary Toxoplasma gondii infection in pregnant women in Norway: twenty years of experience of amniocentesis in a low-prevalence population"],"prefix":"10.1186","volume":"17","author":[{"given":"Gry","family":"Findal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Helbig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guttorm","family":"Haugen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e5l A.","family":"Jenum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Babill","family":"Stray-Pedersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,26]]},"reference":[{"issue":"10","key":"1300_CR1","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1128\/JCM.36.10.2900-2906.1998","volume":"36","author":"PA Jenum","year":"1998","unstructured":"Jenum PA, Stray-Pedersen B, Melby KK, Kapperud G, Whitelaw A, Eskild A, Eng J. Incidence of Toxoplasma gondii infection in 35,940 pregnant women in Norway and pregnancy outcome for infected women. J Clin Microbiol. 1998;36(10):2900\u20136.","journal-title":"J Clin Microbiol"},{"issue":"9556","key":"1300_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0140-6736(07)60072-5","volume":"369","author":"R Thiebaut","year":"2007","unstructured":"Thiebaut R, Leproust S, Chene G, Gilbert R. Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients\u2019 data. Lancet. 2007;369(9556):115\u201322.","journal-title":"Lancet"},{"issue":"9","key":"1300_CR3","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1093\/cid\/cit032","volume":"56","author":"M Wallon","year":"2013","unstructured":"Wallon M, Peyron F, Cornu C, Vinault S, Abrahamowicz M, Kopp CB, Binquet C. Congenital toxoplasma infection: monthly prenatal screening decreases transmission rate and improves clinical outcome at age 3\u00a0years. Clin Infect Dis. 2013;56(9):1223\u201331.","journal-title":"Clin Infect Dis"},{"key":"1300_CR4","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/B978-1-4160-6400-8.00031-6","volume-title":"Infectious diseases of the fetus and newborn infant","author":"MR Remington JS","year":"2011","unstructured":"Remington JS MR, Wilson CB, Desmonts G. Toxoplasmosis. In: Remington JS KJ, editor. Infectious diseases of the fetus and newborn infant. 7th ed. Philadelphia: Saunders\/Elsevier; 2011. p. 918\u20131041.","edition":"7"},{"issue":"6","key":"1300_CR5","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1093\/clinids\/18.6.853","volume":"18","author":"SY Wong","year":"1994","unstructured":"Wong SY, Remington JS. Toxoplasmosis in pregnancy. Clin Infect Dis. 1994;18(6):853\u201361. quiz 862.","journal-title":"Clin Infect Dis"},{"issue":"9167","key":"1300_CR6","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1016\/S0140-6736(98)08220-8","volume":"353","author":"D Dunn","year":"1999","unstructured":"Dunn D, Wallon M, Peyron F, Petersen E, Peckham C, Gilbert R. Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet. 1999;353(9167):1829\u201333.","journal-title":"Lancet"},{"issue":"6","key":"1300_CR7","doi-asserted-by":"publisher","first-page":"552.e551","DOI":"10.1016\/j.ajog.2010.06.002","volume":"203","author":"A Berrebi","year":"2010","unstructured":"Berrebi A, Assouline C, Bessieres MH, Lathiere M, Cassaing S, Minville V, Ayoubi JM. Long-term outcome of children with congenital toxoplasmosis. Am J Obstet Gynecol. 2010;203(6):552.e551\u2013556.","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"1300_CR8","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/BF01701522","volume":"15","author":"M Lebech","year":"1996","unstructured":"Lebech M, Joynson DH, Seitz HM, Thulliez P, Gilbert RE, Dutton GN, Ovlisen B, Petersen E. Classification system and case definitions of Toxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspring. European Research Network on Congenital Toxoplasmosis. Eur J Clin Microbiol Infect Dis. 1996;15(10):799\u2013805.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"8","key":"1300_CR9","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1128\/JCM.35.8.1972-1977.1997","volume":"35","author":"PA Jenum","year":"1997","unstructured":"Jenum PA, Stray-Pedersen B, Gundersen AG. Improved diagnosis of primary Toxoplasma gondii infection in early pregnancy by determination of antitoxoplasma immunoglobulin G avidity. J Clin Microbiol. 1997;35(8):1972\u20137.","journal-title":"J Clin Microbiol"},{"issue":"11","key":"1300_CR10","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1128\/CVI.00333-12","volume":"19","author":"JB Murat","year":"2012","unstructured":"Murat JB, L\u2019Ollivier C, Fricker Hidalgo H, Franck J, Pelloux H, Piarroux R. Evaluation of the new Elecsys Toxo IgG avidity assay for toxoplasmosis and new insights into the interpretation of avidity results. Clin Vaccine Immunol. 2012;19(11):1838\u201343.","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"1300_CR11","first-page":"81","volume":"40","author":"M Lappalainen","year":"2004","unstructured":"Lappalainen M, Hedman K. Serodiagnosis of toxoplasmosis. The impact of measurement of IgG avidity. Ann Ist Super Sanita. 2004;40(1):81\u20138.","journal-title":"Ann Ist Super Sanita"},{"issue":"12","key":"1300_CR12","doi-asserted-by":"publisher","first-page":"e0145519","DOI":"10.1371\/journal.pone.0145519","volume":"10","author":"G Findal","year":"2015","unstructured":"Findal G, Stray-Pedersen B, Holter EK, Berge T, Jenum PA. Persistent low Toxoplasma IgG avidity is common in pregnancy: experience from antenatal testing in Norway. PLoS One. 2015;10(12):e0145519.","journal-title":"PLoS One"},{"issue":"4","key":"1300_CR13","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1086\/590149","volume":"47","author":"JG Montoya","year":"2008","unstructured":"Montoya JG, Remington JS. Management of Toxoplasma gondii infection during pregnancy. Clin Infect Dis. 2008;47(4):554\u201366.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"1300_CR14","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1056\/NEJM198802043180502","volume":"318","author":"F Daffos","year":"1988","unstructured":"Daffos F, Forestier F, Capella-Pavlovsky M, Thulliez P, Aufrant C, Valenti D, Cox WL. Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis. N Engl J Med. 1988;318(5):271\u20135.","journal-title":"N Engl J Med"},{"issue":"1","key":"1300_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000271995","volume":"27","author":"A Tabor","year":"2010","unstructured":"Tabor A, Alfirevic Z. Update on procedure-related risks for prenatal diagnosis techniques. Fetal Diagn Ther. 2010;27(1):1\u20137.","journal-title":"Fetal Diagn Ther"},{"issue":"4","key":"1300_CR16","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/j.1471-0528.2005.00413.x","volume":"112","author":"M Cederholm","year":"2005","unstructured":"Cederholm M, Haglund B, Axelsson O. Infant morbidity following amniocentesis and chorionic villus sampling for prenatal karyotyping. BJOG. 2005;112(4):394\u2013402.","journal-title":"BJOG"},{"issue":"4","key":"1300_CR17","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1046\/j.1471-0528.2003.02091.x","volume":"110","author":"M Cederholm","year":"2003","unstructured":"Cederholm M, Haglund B, Axelsson O. Maternal complications following amniocentesis and chorionic villus sampling for prenatal karyotyping. BJOG. 2003;110(4):392\u20139.","journal-title":"BJOG"},{"key":"1300_CR18","volume-title":"\u00c5rstabeller for medisinsk f\u00f8dselsregister 2010","author":"Norwegian Institute of Public Health","year":"2012","unstructured":"Norwegian Institute of Public Health. \u00c5rstabeller for medisinsk f\u00f8dselsregister 2010. Oslo: Norwegian Institute of Public Health; 2012."},{"issue":"8","key":"1300_CR19","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1086\/319672","volume":"183","author":"O Liesenfeld","year":"2001","unstructured":"Liesenfeld O, Montoya JG, Kinney S, Press C, Remington JS. Effect of testing for IgG avidity in the diagnosis of Toxoplasma gondii infection in pregnant women: experience in a US reference laboratory. J Infect Dis. 2001;183(8):1248\u201353.","journal-title":"J Infect Dis"},{"issue":"2815","key":"1300_CR20","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1126\/science.108.2815.660","volume":"108","author":"AB Sabin","year":"1948","unstructured":"Sabin AB, Feldman HA. Dyes as microchemical indicators of a new immunity phenomenon affecting a protozoon parasite (Toxoplasma). Science. 1948;108(2815):660\u20133.","journal-title":"Science"},{"issue":"7","key":"1300_CR21","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1111\/j.1699-0463.1998.tb00211.x","volume":"106","author":"PA Jenum","year":"1998","unstructured":"Jenum PA, Holberg-Petersen M, Melby KK, Stray-Pedersen B. Diagnosis of congenital Toxoplasma gondii infection by polymerase chain reaction (PCR) on amniotic fluid samples. The Norwegian experience. APMIS. 1998;106(7):680\u20136.","journal-title":"APMIS"},{"issue":"3","key":"1300_CR22","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.diagmicrobio.2009.02.014","volume":"64","author":"L Lachaud","year":"2009","unstructured":"Lachaud L, Calas O, Picot MC, Albaba S, Bourgeois N, Pratlong F. Value of 2 IgG avidity commercial tests used alone or in association to date toxoplasmosis contamination. Diagn Microbiol Infect Dis. 2009;64(3):267\u201374.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"2","key":"1300_CR23","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1128\/CVI.00356-12","volume":"20","author":"O Villard","year":"2013","unstructured":"Villard O, Breit L, Cimon B, Franck J, Fricker-Hidalgo H, Godineau N, Houze S, Paris L, Pelloux H, Villena I, et al. Comparison of four commercially available avidity tests for Toxoplasma gondii-specific IgG antibodies. Clin Vaccine Immunol. 2013;20(2):197\u2013204.","journal-title":"Clin Vaccine Immunol"},{"issue":"2","key":"1300_CR24","doi-asserted-by":"publisher","first-page":"191.e191","DOI":"10.1016\/j.cmi.2014.09.018","volume":"21","author":"AR Prusa","year":"2015","unstructured":"Prusa AR, Kasper DC, Pollak A, Olischar M, Gleiss A, Hayde M. Amniocentesis for the detection of congenital toxoplasmosis: results from the nationwide Austrian prenatal screening program. Clin Microbiol Infect. 2015;21(2):191.e191\u2013198.","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"1300_CR25","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/pd.1715","volume":"27","author":"B Khoshnood","year":"2007","unstructured":"Khoshnood B, De Vigan C, Goffinet F, Leroy V. Prenatal screening and diagnosis of congenital toxoplasmosis: a review of safety issues and psychological consequences for women who undergo screening. Prenat Diagn. 2007;27(5):395\u2013403.","journal-title":"Prenat Diagn"},{"issue":"1","key":"1300_CR26","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1017\/S0950268897008480","volume":"120","author":"PA Jenum","year":"1998","unstructured":"Jenum PA, Kapperud G, Stray-Pedersen B, Melby KK, Eskild A, Eng J. Prevalence of Toxoplasma gondii specific immunoglobulin G antibodies among pregnant women in Norway. Epidemiol Infect. 1998;120(1):87\u201392.","journal-title":"Epidemiol Infect"},{"key":"1300_CR27","unstructured":"KK M, PA J. \u00c5rsrapport 2015. Nasjonalt referanselaboratorium for Toxoplasma-diagnostikk. In.: Avd. for mikrobilologi, Oslo universitetssykehus Rikshospitalet; 2015. https:\/\/oslo-universitetssykehus.no\/fag-og-forskning\/laboratorietjenester\/mikrobiologi\/nasjonalt-referanselaboratorium-for-toxoplasmose ."},{"issue":"12","key":"1300_CR28","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.ijpara.2009.04.003","volume":"39","author":"G Pappas","year":"2009","unstructured":"Pappas G, Roussos N, Falagas ME. Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int J Parasitol. 2009;39(12):1385\u201394.","journal-title":"Int J Parasitol"},{"issue":"2","key":"1300_CR29","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3109\/inf.1979.11.issue-2.12","volume":"11","author":"B Stray-Pedersen","year":"1979","unstructured":"Stray-Pedersen B, Lorentzen-Styr AM. The prevalence of toxoplasma antibodies among 11,736 pregnant women in Norway. Scand J Infect Dis. 1979;11(2):159\u201365.","journal-title":"Scand J Infect Dis"},{"issue":"4","key":"1300_CR30","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/apm.12354","volume":"123","author":"G Findal","year":"2015","unstructured":"Findal G, Barlinn R, Sandven I, Stray-Pedersen B, Nordbo SA, Samdal HH, Vainio K, Dudman SG, Jenum PA. Toxoplasma prevalence among pregnant women in Norway: a cross-sectional study. APMIS. 2015;123(4):321\u20135.","journal-title":"APMIS"},{"issue":"4","key":"1300_CR31","doi-asserted-by":"publisher","first-page":"e0149938","DOI":"10.1371\/journal.pone.0149938","volume":"11","author":"CT Oliveira Azevedo de","year":"2016","unstructured":"de Oliveira Azevedo CT, do Brasil PE, Guida L, Lopes Moreira ME. Performance of polymerase chain reaction analysis of the amniotic fluid of pregnant women for diagnosis of congenital toxoplasmosis: a systematic review and meta-analysis. PLoS One. 2016;11(4):e0149938.","journal-title":"PLoS One"},{"issue":"2","key":"1300_CR32","first-page":"296","volume":"97","author":"S Romand","year":"2001","unstructured":"Romand S, Wallon M, Franck J, Thulliez P, Peyron F, Dumon H. Prenatal diagnosis using polymerase chain reaction on amniotic fluid for congenital toxoplasmosis. Obstet Gynecol. 2001;97(2):296\u2013300.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"1300_CR33","first-page":"14","volume":"7","author":"O Thalhammer","year":"1972","unstructured":"Thalhammer O. Prenatal incubation period (author\u2019s transl). Padiatr Padol. 1972;7(1):14\u20139.","journal-title":"Padiatr Padol"},{"key":"1300_CR34","doi-asserted-by":"publisher","unstructured":"Cortina-Borja M, Tan HK, Wallon M, Paul M, Prusa A, Buffolano W, Malm G, Salt A, Freeman K, Petersen E, et al. Prenatal treatment for serious neurological sequelae of congenital toxoplasmosis: an observational prospective cohort study. PLoS Med. 2010;7(10): e1000351. https:\/\/doi.org\/10.1371\/journal.pmed.1000351 .","DOI":"10.1371\/journal.pmed.1000351"},{"issue":"5","key":"1300_CR35","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1177\/1403494811399653","volume":"39","author":"SE Bjerke","year":"2011","unstructured":"Bjerke SE, Vangen S, Holter E, Stray-Pedersen B. Infectious immune status in an obstetric population of Pakistani immigrants in Norway. Scand J Public Health. 2011;39(5):464\u201370.","journal-title":"Scand J Public Health"},{"issue":"1","key":"1300_CR36","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/uog.15820","volume":"47","author":"CB Wulff","year":"2016","unstructured":"Wulff CB, Gerds TA, Rode L, Ekelund CK, Petersen OB, Tabor A. Risk of fetal loss associated with invasive testing following combined first-trimester screening for Down syndrome: a national cohort of 147 987 singleton pregnancies. Ultrasound Obstet Gynecol. 2016;47(1):38\u201344.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"1300_CR37","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1055\/s-2005-923432","volume":"23","author":"E Mungen","year":"2006","unstructured":"Mungen E, Tutuncu L, Muhcu M, Yergok YZ. Pregnancy outcome following second-trimester amniocentesis: a case\u2013control study. Am J Perinatol. 2006;23(1):25\u201330.","journal-title":"Am J Perinatol"},{"issue":"8493","key":"1300_CR38","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/S0140-6736(86)91218-3","volume":"1","author":"A Tabor","year":"1986","unstructured":"Tabor A, Philip J, Madsen M, Bang J, Obel EB, Norgaard-Pedersen B. Randomised controlled trial of genetic amniocentesis in 4606 low-risk women. Lancet. 1986;1(8493):1287\u201393.","journal-title":"Lancet"},{"issue":"3","key":"1300_CR39","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1097\/AOG.0b013e318162eb53","volume":"111","author":"AO Odibo","year":"2008","unstructured":"Odibo AO, Gray DL, Dicke JM, Stamilio DM, Macones GA, Crane JP. Revisiting the fetal loss rate after second-trimester genetic amniocentesis: a single center\u2019s 16-year experience. Obstet Gynecol. 2008;111(3):589\u201395.","journal-title":"Obstet Gynecol"},{"issue":"2","key":"1300_CR40","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.ejogrb.2013.03.027","volume":"169","author":"C Margioula-Siarkou","year":"2013","unstructured":"Margioula-Siarkou C, Karkanaki A, Kalogiannidis I, Petousis S, Dagklis T, Mavromatidis G, Prapas Y, Prapas N, Rousso D. Operator experience reduces the risk of second trimester amniocentesis-related adverse outcomes. Eur J Obstet Gynecol Reprod Biol. 2013;169(2):230\u20133.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"8","key":"1300_CR41","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1002\/(SICI)1097-0223(199808)18:8<773::AID-PD350>3.0.CO;2-W","volume":"18","author":"S Tharmaratnam","year":"1998","unstructured":"Tharmaratnam S, Sadek S, Steele EK, Harper MA, Stewart FJ, Nevin J, Nevin NC, Dornan JC. Early amniocentesis: effect of removing a reduced volume of amniotic fluid on pregnancy outcome. Prenat Diagn. 1998;18(8):773\u20138.","journal-title":"Prenat Diagn"},{"issue":"3","key":"1300_CR42","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s00404-008-0740-2","volume":"279","author":"FB Cebesoy","year":"2009","unstructured":"Cebesoy FB, Balat O, Pehlivan S, Kutlar I, Dikensoy E, Ugur MG. Is pregnancy loss after amniocentesis related to the volume of amniotic fluid obtained? Arch Gynecol Obstet. 2009;279(3):357\u201360.","journal-title":"Arch Gynecol Obstet"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-017-1300-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T07:22:27Z","timestamp":1601968947000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-017-1300-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,26]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1300"],"URL":"https:\/\/doi.org\/10.1186\/s12884-017-1300-1","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,26]]},"article-number":"127"}}